IP Library Granted Patent US 9,283,248
Granted Patent B2
US 9,283,248 · App. 14/661,804 · Granted Mar 15, 2016

Bi-functional co-polymer use for ophthalmic and other topical and local applications

Inventors: Eugene Rex Cooper (Berwyn, PA); David Maxwell Kleinman (Rochester, NY); Andrew Loxley (Philadelphia, PA); Mark Mitchnick (East Hampton, NY)
Assignee: EYEON PARTICLE SCIENCES LLC
A61K31/785A61K9/0048A61K9/0051A61K31/74A61K31/765A61K35/02A61K45/06A61K47/34G02C7/04A61K9/0043A61K9/5146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,248
App. No.
14/661,804
Granted
Mar 15, 2016
Kind
B2
Abstract

The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.

Claims (9)

1. A method for prolonging the stability of an ocular surface tear film of a subject, comprising contacting said ocular surface of said subject with a composition comprising a graft copolymer having a positively charged PLL backbone and one or more hydrophilic water soluble side chains selected from the group consisting of polyethylene glycols, polysaccharides, poly(meth)acrylates, polyacrylamides, polyvinyl alcohol (PVA), polyethyloxazoline, poly-N-vinyl pyrrolidone (NVP) and poly boronic-based polymers, in an amount and for a duration so as to prolong the stability of said tear film of said subject.

2. The method of claim 1 wherein said graft copolymer creates a covalent linkage between said graft copolymer and said ocular surface.

3. The method of claim 1 , wherein said graft copolymer creates an electrolytic interaction between said graft copolymer and said ocular surface.

4. The method of claim 1 , where the PLL backbone is selected from the group consisting of: poly(L-lysine) (PLL), polylysine, and polyornithine.

5. The method of claim 1 , where said polyethylene glycols are selected from the group consisting of polyethylene glycol, polypropylene glycol, and mixtures thereof.

6. The method of claim 1 , where said polysaccharides are selected from the group consisting of dextran, carboxylated cellulosics, carboxymethyl cellulose, natural gums, carageenan, alginates and hyaluronic acid and mixtures thereof.

7. The method of claim 1 , where poly boronic based polymers are selected from polymers having boronic-based functional groups selected from the group consisting of phenylboronic acid (PBA), 2-carboxyethaneboronic acid, 1,2-dicarboxyethaneboronic acid, .beta. beta.′-d carboxyethaneboronate, beta.gamma.-dicarboxypropaneboronate, 2-nitro- and 4-nitro-3-succinamidobenzene boronic acids, 3-nitro-4-(6-aminohexylamido)phenyl boronic acid, {4-[(hexamethylenetetramine) methyl]phenyllboronic acid, 4-(N-methyl)carboxamidobenzene boronic acid, 2-{[(4-boronphenyl)methyl]-ethylammonio}ethyl and 2-{[(4-boronphenyl) methyl]diethylammoniol-ethyl groups, succinyl-3-aminophenylboronic add, 6-aminocaproyl-3-aminophenylboronic acid, 3-(N succinimidoxycarbonyl) aminophenyl borona-.e, p-(omega.-aminoethyl)phenylboronate, p-vinyl benzeneboronate, N-(3-dihydroxyborylphenyl)succinamic acid, N-(4-rtro-3-dihydroxy borylphenyl)succinamic acid, 0-dimethylaminomethylbenzene boronic acid, 4-carboxy benzene boronic acid, 4-(N-octyl)carboxamido benzene boronic acid, 3-nitro-4-carboxybenzeneboronic acid, 2-nitro-4-carboxybenzene boronic acid, 4-bromophenylboronate, p-vinylbenzene boronate, 4-(.omega.-aminoethyl)phenylboronate, catechol [2-(diethylamino)carbonyl, 4-bromomethyl]phenyl boronate, and 5-vinyl-2-dimethylaminomethyl benzeneboronic acid.

8. The method of claim 4 , wherein said polylysine is selected from the group consisting of poly-D-lysine (PDL), poly-DL-lysine, poly-e-CBZ-D-lysine, poly-e-CBZ-DL-lysine, and poly-e-CBZ-L-lysine).

9. The method of claim 4 , wherein said polyornithine is selected from the group consisting of poly-DL-ornithine, poly-L-ornithine or poly-S-CBZ-DL-ornithine.

Assignments (2)
CHANGE OF NAME Recorded May 6, 2021
From: EYEON PARTICLE SCIENCES, LLC
To: CALM WATER THERAPEUTICS LLC
Reel/Frame 056170/0985 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: COOPER, EUGENE R.; MTICHNICK, MARK A.; KLEINMAN, DAVID M.; LOXLEY, ANDREW
To: EYEON PARTICLE SCIENCES LLC
Reel/Frame 037157/0968 →
Continuity (4)
Continuation 14328484 · Jul 10, 2014
Continuation 12708329 · Feb 18, 2010
Provisional Application 61153416 · Feb 18, 2009
Related Publication 20150190422A1 · Jul 9, 2015